Remyelination

Links shared publicly online about this topic

MS Society-funded Study Unlocks Part Of The Mystery Of Remyelination In MS

medicalnewstoday.com — “Researchers working in Cambridge and San Francisco have discovered clues about how stem cells promote myelin repair. The study, published earlier this week in the journal Genes and Development, wView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 10, 2009 at 1:37 pm By:

LisaEmrich Lisa Emrich Patient Expert

MedNewsToday: MS Society-funded Study Unlocks Part Of The Mystery Of Remyelination In MS: Researche.. http://tinyurl.com/nffz64

3 years ago...

MRI Data Showing Tysabri® Promoted Remyelination Presented At The 61st Annual Meeting Of The American Academy Of Neurology

medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced results of a study demonstrating that TYSABRI® (natalizumab) promoted regeneration and stabilization of damage done tView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 2, 2009 at 3:02 pm By:

LisaEmrich Lisa Emrich Patient Expert

MedNewsToday: MRI Data Showing Tysabri® Promoted Remyelination Presented At The 61st Annual Meeting.. http://tinyurl.com/c2javd

3 years ago...

Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination - Ma - 2011 - Journal of Neuroscience Research - Wiley Online Library

onlinelibrary.wiley.com — “Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination - Ma - 2011 - Journal of Neuroscience Research - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on February 23, 2011 at 10:08 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelinatio... http://bit.ly/gE5OQo

12 months ago...

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis - Drugs.com MedNews

drugs.com — “DR6 antagonist may play dual role in preventing axonal Jul 3, 2011 - Biogen Idec (NASDAQ BIIB), a leader in the research and development of treatments for peoplView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 5, 2011 at 2:01 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Acti... http://bit.ly/lGQaCY #drug

7 months ago...

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.net

finanzen.net — “Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.netView full resource at finanzen.net

  • View Related
  • Share

Most Recently Shared on July 3, 2011 at 9:56 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation... http://bit.ly/k3FOM9

7 months ago...

Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non-Human Primate Model of Multiple Sclerosis by Correcting Tissue Hypothyroidism - D’Intino - 2011 - Journal of Neuroendocrinology - Wiley Online Library

onlinelibrary.wiley.com — “Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non-Human Primate Model of Multiple Sclerosis by Correcting Tissue Hypothyroidism - D’Intino - 2011 - Journal of Neuroendocrinology - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on August 13, 2011 at 4:09 am By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non‐Human Primate Model... http://t.co/VOLCFJm

6 months ago...

Zocor may block nerve repair

healthcentral.com — “Zocor may block nerve repairView full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on June 12, 2009 at 3:07 pm By:

Researchers Report That Thymosin Beta 4 Improves Neurological Function After Stroke

medicalnewstoday.com — “RegeneRx Biopharmaceuticals, Inc. (NYSE Alternext US:RGN) announced that a research team from the Henry Ford Hospital in Detroit, MI reported that Thymosin beta 4 (T4), administered to rats oneView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 8, 2010 at 6:06 pm By:

mnt_stroke MNT Stroke News Health News

Researchers Report That Thymosin Beta 4 Improves Neurological Function After Stroke http://mnt.to/3yD4 #stroke

2 years ago...

Neurology Medical News about Hyaluronic Acid

mdlinx.com — “Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 2, 2010 at 3:12 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2: Proceedi... http://bit.ly/9vnZjt #neurology #mdlinx

2 years ago...

Simvastatin interferes with process outgrowth and ... [J Neurosci Res. 2010] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on September 23, 2010 at 11:51 pm By:

Hopes for Reversing Age-Associated Effects in MS Patients | Neuroscience News

neurosciencenews.com — “Proof of principle study suggests the age-associated decline of the remyelination process is reversible New research highlights the possibility of reversingView full resource at neurosciencenews.com

  • View Related
  • Share

Most Recently Shared on January 7, 2012 at 12:12 am By:

Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination : Nature Medicine : Nature Publishing Group

nature.com — “The multiple sclerosis brain shows massive demyelination. Now, Sha Mi and colleagues show that upregulation of DR6 in multiple sclerosis brain is responsible for inhibiting remyelination and brain repair by oligodendrocytes.View full resource at nature.com

  • View Related
  • Share

Most Recently Shared on July 4, 2011 at 8:00 pm By:

westr westr Doctor, Health Social Media, and PhD

#MS RT @nutrigenomics: gr8 @NatureMedicine Death receptor 6 negatively regulates oligodendrocyte ......http://goo.gl/AXQLO

7 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • LisaEmrich

    Lisa Emrich

    Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com

    View Profile

  • LisaEmrich

    Lisa Emrich

    Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com

    View Profile

  • MS_Wisdom2

    OrganizedWisdom MS

    Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390